Announcements Trials
Browse Landscape

Phase

Phase 4 7Phase 3 6Phase 2 3Phase 2/3 1Phase 1 1

Status

Completed 3Unknown 2Terminated 1

Sponsor Class

INDUSTRY 6OTHER 3

Study Type

Interventional 6

Sponsor

Conditions

Cancer Pain 3Pain 2Neoplasms 2Non Cancer Pain 1

Interventions

Carboplatin 314Paclitaxel 302Cisplatin 250Docetaxel 237pembrolizumab 230Gemcitabine 213Pemetrexed 158Capecitabine 147Rituximab 144Bevacizumab 142Dexamethasone 125Fluorouracil 120Cyclophosphamide 102Trastuzumab 100Doxorubicin 96Nivolumab 92Prednisone 91Oxaliplatin 89atezolizumab 73Leucovorin 71durvalumab 69130-nm albumin-bound paclitaxel 67Injections 64Lenalidomide 63Irinotecan 60Bortezomib 55Letrozole 54Topotecan 53Fulvestrant 53Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × INDUSTRY × Oxycodone × Clear all
NCT04808531 2022-04-12

NanaBisâ„¢ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers

Medlab Clinical

Phase 3 Unknown
360 enrolled

Cancer Pain

NCT01885182 2019-10-04

Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 3 Completed
232 enrolled 16 charts

Neoplasms, Pain

NCT00626600 2018-10-24

A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion

Mundipharma Research Limited

Phase 3 Terminated
33 enrolled

Cancer Pain

NCT01675622 2018-05-21

Immediate-Release Oxycodone Capsules Study in Cancer Pain

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 3 Completed
242 enrolled 20 charts

Cancer Pain, Neoplasms

NCT01918098 2017-11-14

Targin for Non-cancer Pain

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 3 Completed
230 enrolled

Non Cancer Pain

NCT00822614 2009-01-14

FINDS

Akela Pharma, Inc.

Phase 3 Unknown
500 enrolled

Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡